Assistance in gaining access to DOJOLVI
UltraCare services are designed to help facilitate patient access to DOJOLVI treatment.
Enrolling in UltraCare may help your patients to:
- Understand their insurance coverage
- Access resources in the Patient Support Program
Download a DOJOLVI Patient Enrolment Form to start the enrolment process
Fill out the form with your patient and fax it to 1-833-592-2273 (CARE). Please note that a completed form is required for your enrolment.
For additional support, please call 1-833-388-5872 (U-LTRA).
Indication and clinical use
DOJOLVI® (triheptanoin) is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders (LC-FAOD).
Please consult the Product Monograph at www.ultragenyx.com/canada/medicines/dojolvi-product-monograph-CANADA/ for important information on warnings and precautions, the conditions of clinical use, adverse reactions, drug interactions and dosing instructions.
The Product Monograph is also available by calling us at 1-833-388-5872.
Indication and clinical use
DOJOLVI® (triheptanoin) is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders (LC-FAOD).
Please consult the Product Monograph at www.ultragenyx.com/canada/medicines/dojolvi-product-monograph-CANADA/ for important information on warnings and precautions, the conditions of clinical use, adverse reactions, drug interactions and dosing instructions.
The Product Monograph is also available by calling us at 1-833-388-5872.
For additional information and questions about medical information or medical affairs, please contact Ultragenyx Medical Affairs at 1-833-388-5872 (U-LTRA).